Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.

@article{Wawrzynczak1992MolecularAB,
  title={Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.},
  author={E. Wawrzynczak and U. Zangemeister‐Wittke and R. Waibel and R. Henry and G. Parnell and A. Cumber and M. Jones and R. Stahel},
  journal={British Journal of Cancer},
  year={1992},
  volume={66},
  pages={361 - 366}
}
An immunotoxin (IT) comprising abrin A chain attached to the mouse monoclonal antibody SWA11, recognising a cell surface antigen highly associated with human small cell lung cancer (SCLC), was synthesised using a hindered disulphide crosslinker, N-succinimidyl 3-(2-pyridyldithio) butyrate (SPDB), and purified by Blue Sepharose CL-6B affinity chromatography. The IT preparation contained monomeric conjugate, composed of one abrin A chain molecule linked to one SWA11 molecule, and was free from… Expand
View on Nature
nature.com
16 Citations
Highly Influential Citations
1
Background Citations
4

16 Citations

Citation Type

Citation Type

Anti‐tumor activity of a blocked ricin immunotoxin with specificity against the cluster‐5A antigen associated with human small‐cell lung cancer
Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate
Abrin-a A chain expressed as soluble form in Escherichia coli from a PCR-synthesized gene is catalytically and functionally active.
The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line
Exploring Cytotoxic mRNAs as a Novel Class of Anti-cancer Biotherapeutics
Immunotoxins as cancer chemotherapeutic agents
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas.
Action of a cd24‐specific deglycosylated ricin‐a‐chain immunotoxin in conventional and novel models of small‐cell‐lung‐cancer xenograft
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
...
1
2
...

References

SHOWING 1-10 OF 26 REFERENCES
Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75.
The low uptake of an abrin A-chain immunotoxin by rat hepatic cells in vivo and in vitro.
Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
Comparative biochemical, cytotoxic and pharmacokinetic properties of immunotoxins made with native ricin a chain, ricin A1 chain and recombinant ricin a chain
Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages.
Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
...
1
2
3
...